HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Advances in therapeutics for neurodegenerative tauopathies: moving toward the specific targeting of the most toxic tau species.

Abstract
Neurodegenerative disease is one of the greatest health concerns today and with no effective treatment in sight, it is crucial that researchers find a safe and successful therapeutic. While neurofibrillary tangles are considered the primary tauopathy hallmark, more evidence continues to come to light to suggest that soluble, intermediate tau aggregates--tau oligomers--are the most toxic species in disease. These intermediate tau species may also be responsible for the spread of pathology, suggesting that oligomeric tau may be the best therapeutic target. Here, we summarize results for the modulation of tau by molecular chaperones, small molecules and aggregation inhibitors, post-translational modifications, immunotherapy, other techniques, and future directions.
AuthorsJulia E Gerson, Diana L Castillo-Carranza, Rakez Kayed
JournalACS chemical neuroscience (ACS Chem Neurosci) Vol. 5 Issue 9 Pg. 752-69 (Sep 17 2014) ISSN: 1948-7193 [Electronic] United States
PMID25075869 (Publication Type: Journal Article, Review)
Chemical References
  • Antibodies
  • tau Proteins
Topics
  • Animals
  • Antibodies (therapeutic use)
  • Humans
  • Neurodegenerative Diseases (therapy)
  • Protein Processing, Post-Translational (drug effects, genetics)
  • Signal Transduction (drug effects)
  • tau Proteins (chemistry, genetics, immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: